Study: Less is better when it comes to aspirin after heart procedure

12/19/2012 | MedPage Today (free registration)

Higher doses of aspirin were associated with greater bleeding risks but not better ischemia outcomes, according to an analysis of data on 2,851 people treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction. The study in the Journal of the American College of Cardiology: Cardiovascular Interventions examined data from the HORIZONS-AMI trial.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI